PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.3990
-0.0031 (-0.77%)
At close: Nov 11, 2026, 4:00 PM EST
0.3900
-0.0090 (-2.26%)
After-hours: Nov 11, 2026, 6:27 PM EST
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $4.28 million as of November 11, 2026. It is the 45,431st most valuable company in the world and the 6,012th biggest in the United States. Its market cap has decreased by 26.15% in one year.
Market Cap
4.28M
Enterprise Value
-26.23M
1-Year Change
-26.15%
Global Rank
Country Rank
#6,012 United States
Category
ChartMarket Cap Chart
Since August 10, 2021, PharmaCyte Biotech's market cap has decreased from $4.90M to $4.28M, a decrease of -12.58%. That is a compound annual growth rate of -2.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 4.28M | -41.32% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 957.14% |
| Aug 10, 2021 | 4.90M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Niki BioSolutions | 4.61M |
| AIM ImmunoTech | 4.52M |
| Xenetic Biosciences | 4.37M |
| Creative Medical Technology Holdings | 4.15M |
| Alaunos Therapeutics | 4.09M |
| Skye Bioscience | 4.07M |
| NuCana | 4.05M |
| Imunon | 4.04M |